The DEXACELL trial—a protocol for a pragmatic, multicentre, double-blind, placebo-controlled, randomised, parallel group, phase 3 superiority trial to assess the effectiveness and cost-effectiveness of DEXAmethasone as an adjunctive therapy for the management of CELLulitis in adults presenting to urgent secondary care in the UK

Introduction Cellulitis is a common bacterial skin infection causing significant pain, swelling and impact on daily activities, frequently leading to emergency department presentations and hospital admissions. While antibiotics are the mainstay of treatment, they do not directly address inflammation...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Matthew J Ridd, Christopher Hayward, David Arnold, Edward Carlton, Hazel Taylor, Annie Hawton, Daniel S Lasserson, Siobhan Creanor, Heather Cook, Katherine Joyce, Fergus W Hamilton, O Martin Williams, David Rowe, James Connors, Elizabeth Goodwin, Phoebe Dawe, Rebecca Lear, Ella Chaudhuri, Debbie Shipley, Hannah E Wainman
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMJ Publishing Group 2025-10-01
coleção:	BMJ Open
Acesso em linha:	https://bmjopen.bmj.com/content/15/10/e109953.full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!